COLL vs NTAP · P/E 17, rev $181.9M vs P/E 28, rev $6.57B
Collegium Pharmaceutical Inc (COLL) versus NetApp Inc (NTAP) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported NTAP revenue for 2025-04-25 was $6.57B. Net income was $1.19B. Revenue was up 4.9% from 2024-04-26 to 2025-04-25. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Not investment advice. Open the COLL and NTAP stock pages for the full models.
Not investment advice.